Professional Biography
Paul Cleaveland is a consultant urologist and robotic surgeon at the Circle Alexandra Hospital, Circle Cheshire Clinic and HCA the Christie clinic. His practice includes general urology and robotic surgery with a subspecialty interest in prostate cancer, bladder cancer, testicular cancer and male lower urinary tracts symptoms due to benign prostatic enlargement.
He graduated from the University of Birmingham medical school in 2009 and then moved to Manchester to complete foundation training. He completed core surgical training and urology specialty training in the North West region. During this time he completed a Post-graduate Certificate in Workplace Based Post-graduate Medical Education at Edge Hill University. He began a subspecialty interest in robotic and pelvic oncology surgery while training at the Christie Hospital and Stepping Hill Hospital. Having completed specialty training in urology he went onto a fellowship in robotic surgery for pelvic urological oncology at the University College London Hospitals Foundation Trust, the highest volume centre in the country for prostatectomy. This involved training in robotic radical prostatectomy, robotic cystectomy, robotic urinary diversions and open complex pelvic and reconstructive surgery for the treatment of pelvic cancers. He completed an observership at the Martini-Klinik am UKE GmbH in Hamburg, the highest volume centre in Europe for prostatectomy.
Mr. Cleaveland was appointed in 2020 as a consultant urologist at Stockport NHS Foundation Trust with clinics in Macclesfield, Tameside and Leighton trusts. He treats general urology conditions including urinary symptoms, incontinence, urinary tract infections, blood in the urine or semen, urinary retention and erectile dysfunction.
Mr. Cleaveland performs Retzius-sparing robotic prostatectomy as a treatment for prostate cancer. This technique improves functional recovery in men with prostate cancer, in particular the early recovery of urinary function. He performs diagnostics in men suspected of having prostate cancer with MRI and ultra-sound guided trans-perineal targeted prostate biopsies. He performs diagnostics in men suspected of having bladder cancer with flexible cystoscopy and treatment of bladder cancers with transurethral resection of bladder tumour and laser ablation.
Mr. Cleaveland also has an interest in the treatment of benign prostatic disease and male urinary symptoms including medical management and surgical treatment. He performs bipolar transurethral resection of prostate, Rezum water vaporisation of prostate and robotic simple prostatectomy for the treatment of benign prostatic enlargement. He performs circumcision, hydrocoele repair, orchidectomy and vasectomy.
He is actively involved in training medical students and examining for Manchester University medical school. He trains specialty trainees and international fellows in robotic surgery and general urology. He is involved in the national selection of urology trainees into the national training programme and is a faculty member at the FRCS urology exam revision course. As part of the regional urology specialty training programme he delivers lectures on prostate cancer treatment. Paul is cancer lead for urology at his trust and is involved in improvement of cancer services and urological cancer diagnostic pathways. He is involved in quality improvement, audit and has previously been the audit lead for the urology department at his trust. He is actively involved in research with various publications in peer reviewed journals and book chapters in the field of urology, oncology and robotic surgery. He has also given presentations at international conferences in the field of urology and robotic surgery.